ImmunityBio (IBRX) EBT Margin (QoQ) (2014 - 2026)
ImmunityBio (IBRX) EBT Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126,927.00 |
| Dec 31, 2025 | 4,775.00 |
| Sep 30, 2025 | 13,937.00 |
| Jun 30, 2025 | 43,715.00 |
| Mar 31, 2025 | -284.00 |
| Dec 31, 2024 | 62,077.00 |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 32.25 Mn |
| Mar 31, 2024 | -16.74 Mn |
| Dec 31, 2023 | -5.13 Mn |
| Sep 30, 2023 | 22.05 Mn |
| Jun 30, 2023 | -30.47 Mn |
| Mar 31, 2023 | 11.60 Mn |
| Dec 31, 2022 | -5.41 Mn |
| Sep 30, 2022 | 17.68 Mn |
| Jun 30, 2022 | 46.47 Mn |
| Mar 31, 2022 | -71.22 Mn |
| Dec 31, 2021 | 11.05 Mn |
| Sep 30, 2021 | -10.76 Mn |
| Jun 30, 2021 | 3.15 Mn |